Evidence map›Paper›PMID 18263878›Full record

ArticleThe Journal of biological chemistry2008

Tip60 is required for DNA interstrand cross-link repair in the Fanconi anemia pathway.

James Hejna, Megan Holtorf, Jennie Hines, Lauren Mathewson, Aaron Hemphill, Muhsen Al-Dhalimy, Susan B Olson, Robb E Moses

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. DNA transcription and repair: a confluence.The Journal of biological chemistry · 2012
    Review
  12. DNA interstrand crosslink repair in mammalian cells: step by step.Critical reviews in biochemistry and molecular biology · 2010
    Review
  13. DNA interstrand crosslink repair in mammalian cells.Journal of cellular physiology · 2009
    Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

James HejnaDepartment of Molecular and Medical Genetics, Oregon Health & Science University, 3181 Sam Jackson Parkway, Portland, OR 97239, USA.
Megan Holtorf
Jennie Hines
Lauren Mathewson
Aaron Hemphill
Muhsen Al-Dhalimy
Susan B Olson
Robb E Moses
Oregon Health & Science University · US

Funding

Xenograft CoreP01HL048546 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI GROMPE, MARKUS · 1994 to 2020
$36.4M
NHLBI NIH HHS 1P01 HL 48546NHLBI NIH HHS P01 HL048546
6 · The paper itself

Abstract

The disease Fanconi anemia is a genome instability syndrome characterized by cellular sensitivity to DNA interstrand cross-linking agents, manifest by decreased cellular survival and chromosomal aberrations after such treatment. There are at least 13 proteins acting in the pathway, with the FANCD2 protein apparently functioning as a late term effecter in the maintenance of genome stability. We find that the chromatin remodeling protein, Tip60, interacts directly with the FANCD2 protein in a yeast two-hybrid system. This interaction has been confirmed by co-immunoprecipitation and co-localization using both endogenous and epitope-tagged FANCD2 and Tip60 from human cells. The observation of decreased cellular survival after exposure to mitomycin C in normal fibroblasts depleted for Tip60 indicates a direct function in interstrand cross-link repair. The coincident function of Tip60 and FANCD2 in one pathway is supported by the finding that depletion of Tip60 in Fanconi anemia cells does not increase sensitivity to DNA cross-links. However, depletion of Tip60 did not reduce monoubiquitination of FANCD2 or its localization to nuclear foci following DNA damage. The observations indicate that Fanconi anemia proteins act in concert with chromatin remodeling functions to maintain genome stability after DNA cross-link damage.

Indexed as

Active Transport, Cell NucleusCell LineCell NucleusCell SurvivalChromatin Assembly and DisassemblyCross-Linking ReagentsDNA DamageDNA RepairFanconi AnemiaFanconi Anemia Complementation Group D2 ProteinGenomic InstabilityHistone AcetyltransferasesHumansLysine Acetyltransferase 5MitomycinUbiquitinationCross-Linking ReagentsFANCD2 protein, humanFanconi Anemia Complementation Group D2 ProteinHistone AcetyltransferasesKAT5 protein, humanLysine Acetyltransferase 5Mitomycin

Identifiers

PMID18263878
PMCPMC2398728
OpenAlexW1969589499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.